Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2026 Filed May 29, 2026 21:35 UTC |
Valdez Arthur L JrDirector
|
GrantRestricted Stock Units · Derivative | 1,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001821687-26-000002 · form4-05292026_090506.xml · derivative · entry 1 Valdez Arthur L Jr · CIK 0001821687 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F2 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:34 UTC |
WASHINGTON MIRONDirector
|
GrantRestricted Stock Units · Derivative | 1,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001969449-26-000002 · form4-05292026_090557.xml · derivative · entry 3 WASHINGTON MIRON · CIK 0001969449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F3 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:34 UTC |
WASHINGTON MIRONDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001969449-26-000002 · form4-05292026_090557.xml · derivative · entry 2 WASHINGTON MIRON · CIK 0001969449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: On June 5, 2024, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. F2 · derivative.expiration_date: On June 5, 2024, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:34 UTC |
WASHINGTON MIRONDirector
|
Exercise / conversionCommon Stock | 3,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001969449-26-000002 · form4-05292026_090557.xml · nonDerivative · entry 1 WASHINGTON MIRON · CIK 0001969449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:32 UTC |
PADVAL UMESHDirector
|
GrantRestricted Stock Units · Derivative | 1,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001300840-26-000002 · form4-05292026_090545.xml · derivative · entry 3 PADVAL UMESH · CIK 0001300840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F3 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:32 UTC |
PADVAL UMESHDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001300840-26-000002 · form4-05292026_090545.xml · derivative · entry 2 PADVAL UMESH · CIK 0001300840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. F2 · derivative.expiration_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:32 UTC |
PADVAL UMESHDirector
|
Exercise / conversionCommon Stock | 3,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001300840-26-000002 · form4-05292026_090545.xml · nonDerivative · entry 1 PADVAL UMESH · CIK 0001300840 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:31 UTC |
Sanghi SteveDirector
|
GrantRestricted Stock Units · Derivative | 2,085 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001181928-26-000026 · form4-05292026_090516.xml · derivative · entry 4 Sanghi Steve · CIK 0001181928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,085 Underlying: Common Stock · 2,085 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F3 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:31 UTC |
Sanghi SteveDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001181928-26-000026 · form4-05292026_090516.xml · derivative · entry 3 Sanghi Steve · CIK 0001181928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: On June 5, 2025, the reporting person was granted 3,425 RSUs. These RSUs fully vested on May 28, 2026. F2 · derivative.expiration_date: On June 5, 2025, the reporting person was granted 3,425 RSUs. These RSUs fully vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:31 UTC |
Sanghi SteveDirector
|
Exercise / conversionCommon Stock | 3,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001181928-26-000026 · form4-05292026_090516.xml · nonDerivative · entry 1 Sanghi Steve · CIK 0001181928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:30 UTC |
Rao MeeraDirector
|
GrantRestricted Stock Units · Derivative | 1,896 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001480603-26-000002 · form4-05292026_090505.xml · derivative · entry 3 Rao Meera · CIK 0001480603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,896 Underlying: Common Stock · 1,896 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on May 28, 2027. F3 · derivative.expiration_date: The restricted stock units will fully vest on May 28, 2027. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:30 UTC |
Rao MeeraDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,114 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001480603-26-000002 · form4-05292026_090505.xml · derivative · entry 2 Rao Meera · CIK 0001480603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Impinj common stock. F2 · derivative.exercise_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. F2 · derivative.expiration_date: On June 5, 2025, the reporting person was granted 3,114 RSUs. These RSUs fully vested on May 28, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:30 UTC |
Rao MeeraDirector
|
Exercise / conversionCommon Stock | 3,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001480603-26-000002 · form4-05292026_090505.xml · nonDerivative · entry 1 Rao Meera · CIK 0001480603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2026 Filed Jun 9, 2026 21:00 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
OtherCommon Stock | 180,000 | $156.68 | $28,201,500.00 |
DisclosureSEC source: 0001677721-26-000006 · form4-06092026_050601.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 390,302 F1 · kind: For estate planning purposes, on May 26, 2026 (the "Transfer Date"), Dr. Chris Diorio ("Dr. Diorio") received 180,000 shares of the issuer's common stock from the 2012 Diorio Descendants Irrevocable Trust (the "Diorio Trust") in exchange for the simultaneous transfer by Dr. Diorio of 180,000 shares of the issuer's common stock to the Diorio Trust. The estimated per-share value was $156.675, the average of the high and low sales prices of a share of the issuer's common stock on the Transfer Date. F2 · kind: The exchange of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. F1 · price: For estate planning purposes, on May 26, 2026 (the "Transfer Date"), Dr. Chris Diorio ("Dr. Diorio") received 180,000 shares of the issuer's common stock from the 2012 Diorio Descendants Irrevocable Trust (the "Diorio Trust") in exchange for the simultaneous transfer by Dr. Diorio of 180,000 shares of the issuer's common stock to the Diorio Trust. The estimated per-share value was $156.675, the average of the high and low sales prices of a share of the issuer's common stock on the Transfer Date. Read SEC document |
| May 26, 2026 Filed Jun 9, 2026 21:00 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
OtherCommon Stock | 180,000 | $156.68 | $28,201,500.00 |
DisclosureSEC source: 0001677721-26-000006 · form4-06092026_050601.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 570,302 F1 · kind: For estate planning purposes, on May 26, 2026 (the "Transfer Date"), Dr. Chris Diorio ("Dr. Diorio") received 180,000 shares of the issuer's common stock from the 2012 Diorio Descendants Irrevocable Trust (the "Diorio Trust") in exchange for the simultaneous transfer by Dr. Diorio of 180,000 shares of the issuer's common stock to the Diorio Trust. The estimated per-share value was $156.675, the average of the high and low sales prices of a share of the issuer's common stock on the Transfer Date. F2 · kind: The exchange of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. F1 · price: For estate planning purposes, on May 26, 2026 (the "Transfer Date"), Dr. Chris Diorio ("Dr. Diorio") received 180,000 shares of the issuer's common stock from the 2012 Diorio Descendants Irrevocable Trust (the "Diorio Trust") in exchange for the simultaneous transfer by Dr. Diorio of 180,000 shares of the issuer's common stock to the Diorio Trust. The estimated per-share value was $156.675, the average of the high and low sales prices of a share of the issuer's common stock on the Transfer Date. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:36 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 12,706 | $154.46 | $1,962,568.76 |
DisclosureSEC source: 0002003074-26-000005 · primary_doc.xml · nonDerivative · entry 5 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,022,171 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:36 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 24,126 | $154.46 | $3,726,501.96 |
DisclosureSEC source: 0002003074-26-000005 · primary_doc.xml · nonDerivative · entry 4 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,034,877 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:27 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 12,706 | $154.46 | $1,962,568.76 |
DisclosureSEC source: 0002003074-26-000004 · primary_doc.xml · nonDerivative · entry 5 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,022,171 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 11, 2026 Filed May 12, 2026 22:27 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 24,126 | $154.46 | $3,726,501.96 |
DisclosureSEC source: 0002003074-26-000004 · primary_doc.xml · nonDerivative · entry 4 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,034,877 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:36 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 9,522 | $149.97 | $1,428,014.34 |
DisclosureSEC source: 0002003074-26-000005 · primary_doc.xml · nonDerivative · entry 3 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,059,003 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:36 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 1,560 | $151.32 | $236,059.20 |
DisclosureSEC source: 0002003074-26-000005 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,068,525 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:36 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 25,896 | $152.73 | $3,955,096.08 |
DisclosureSEC source: 0002003074-26-000005 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,070,085 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:27 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 9,522 | $149.97 | $1,428,014.34 |
DisclosureSEC source: 0002003074-26-000004 · primary_doc.xml · nonDerivative · entry 3 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,059,003 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:27 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 1,560 | $151.32 | $236,059.20 |
DisclosureSEC source: 0002003074-26-000004 · primary_doc.xml · nonDerivative · entry 2 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,068,525 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:27 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 25,896 | $152.73 | $3,955,096.08 |
DisclosureSEC source: 0002003074-26-000004 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,070,085 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 07, 2026 Filed May 11, 2026 19:11 UTC |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 36,171 | $152.73 | $5,524,396.83 |
DisclosureSEC source: 0002003074-26-000002 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1)&(2) Disclosed balance after: 1,132,152 F1 · ownership.nature: (1) Sylebra Capital Limited (Sylebra HK) is the investment sub-adviser to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Parc Master Fund (PARC MF),Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK. Daniel Gibson (Mr. Gibson) owns more than 99% of the shares of Sylebra Cayman. In such capacities, Sylebra HK, Sylebra Cayman and Mr. Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, PARC MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Mr. Gibson is a member of the board of directors of the Issuer. Sylebra HK, Sylebra US, Sylebra Cayman and Mr. Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra HK, Sylebra US, Sylebra Cayman and Mr. Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| May 07, 2026 Filed May 11, 2026 23:16 UTC Amendment |
SYLEBRA CAPITAL LLCDirector
|
SaleCommon Stock | 36,171 | $152.73 | $5,524,396.83 |
DisclosureSEC source: 0002003074-26-000003 · primary_doc.xml · nonDerivative · entry 1 SYLEBRA CAPITAL LLC · CIK 0002003074 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote (1) (2) Disclosed balance after: 1,095,981 F1 · ownership.nature: (1) Sylebra Capital LLC (Sylebra US) and Sylebra Capital Limited (Sylebra HK) are the investment sub-advisers to Sylebra Capital Partners Master Fund, Ltd. (SCPMF), Sylebra Capital Menlo Master Fund (MENLO MF), and other advisory clients. Sylebra Capital Management (Sylebra Cayman) is the investment manager and parent of Sylebra HK. Sylebra Cayman owns 100% of the shares of Sylebra HK and Daniel Patrick Gibson (Gibson) owns more than 100% of the Class A shares of Sylebra Cayman and 100% of the share capital of Sylebra US. Gibson is a founder and Chief Investment Officer of Sylebra Cayman. In such capacities, Sylebra US, Sylebra HK, Sylebra Cayman and Gibson may be deemed to share voting and dispositive power over the shares of common stock of the Issuer held by SCP MF, MENLO MF, and other advisory clients. F2 · ownership.nature: (2) These securities are held by SCP MF, MENLO MF, and other advisory clients. Gibson is a member of the board of directors of the Issuer. Sylebra US, Sylebra HK, Sylebra Cayman and Gibson disclaim beneficial ownership of these securities, and this report shall not be deemed an admission that Sylebra US, Sylebra HK, Sylebra Cayman and Gibson are the beneficial owners of such securities, except to the extent of their pecuniary interest, if any, therein. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 7,627 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · derivative · entry 8 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,627 Underlying: Common Stock · 7,627 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F6 · derivative.exercise_date: One-fourth of the shares subject to the grant shall vest on March 23, 2027, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date. F6 · derivative.expiration_date: One-fourth of the shares subject to the grant shall vest on March 23, 2027, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 597 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · derivative · entry 7 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,773 Underlying: Common Stock · 597 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on March 23, 2026. F5 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 9,545 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · derivative · entry 6 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,917 Underlying: Common Stock · 479 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on March 23, 2026. F4 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 7,665 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 782 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · derivative · entry 5 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 782 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2022, the reporting person was granted 12,500 RSUs. One-sixteenth of these vested on March 23, 2026. F3 · derivative.expiration_date: On March 23, 2022, the reporting person was granted 12,500 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 732 | $101.17 | $74,056.44 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · nonDerivative · entry 4 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,003 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 597 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:34 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000002 · form4-03242026_080311.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 24,806 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · derivative · entry 9 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,806 Underlying: Common Stock · 24,806 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F6 · derivative.exercise_date: One-fourth of the shares subject to the grant shall vest on March 23, 2027, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date. F6 · derivative.expiration_date: One-fourth of the shares subject to the grant shall vest on March 23, 2027, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · derivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,538 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on March 23, 2026. F5 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · derivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,895 Underlying: Common Stock · 1,224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on March 23, 2026. F4 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 2,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · derivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F3 · derivative.exercise_date: On March 23, 2022, the reporting person was granted 41,500 RSUs. One-sixteenth of these vested on March 23, 2026. F3 · derivative.expiration_date: On March 23, 2022, the reporting person was granted 41,500 RSUs. One-sixteenth of these vested on March 23, 2026. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 2,218 | $101.17 | $224,395.06 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,302 F1 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of restricted stock units, or RSUs. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 1,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 24, 2026 20:31 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 2,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000005 · form4-03242026_080342.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 21:38 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,234 | $127.92 | $285,773.28 |
DisclosureSEC source: 0001705407-26-000001 · form4-02232026_090223.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,877 F2 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of the PSUs. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 21:38 UTC |
Baker CaryCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 8,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001705407-26-000001 · form4-02232026_090223.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,111 F1 · shares: On March 23, 2023, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On February 18, 2026, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 8,508 shares of Common Stock underlying the PSUs. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 21:35 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 7,435 | $127.92 | $951,085.20 |
DisclosureSEC source: 0001677721-26-000004 · form4-02232026_090258.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,885 F2 · kind: In an exempt disposition to the Issuer under Rule 16b-3(e), the Reporting Person remitted shares to the Issuer in connection with the satisfaction of tax withholding obligations arising out of the vesting of the PSUs. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 21:35 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 21,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000004 · form4-02232026_090258.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,320 F1 · shares: On March 23, 2023, the Reporting Person was granted performance restricted stock units (PSUs). The PSUs vested upon the Reporting Person's satisfaction of certain performance criteria. On February 18, 2026, the Issuer's Board of Directors determined the level at which the corporate performance goals were attained, resulting in the vesting of 21,734 shares of Common Stock underlying the PSUs. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:17 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
GiftCommon Stock | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001677721-26-000002 · form4-02192026_090257.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,586 Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 23:18 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-25-000009 · form4-12232025_111256.xml · derivative · entry 8 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,355 Underlying: Common Stock · 1,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on December 23, 2025. F5 · derivative.expiration_date: On March 23, 2024, the reporting person was granted 29,075 RSUs. One-sixteenth of these vested on December 23, 2025. Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 23:18 UTC |
DIORIO CHRIS PH.D.Director · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001677721-25-000009 · form4-12232025_111256.xml · derivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,119 Underlying: Common Stock · 1,224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on December 23, 2025. F4 · derivative.expiration_date: On March 23, 2023, the reporting person was granted 19,580 RSUs. One-sixteenth of these vested on December 23, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.